Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G49108TO
Summary
- GlyTouCan ID
-
G49108TO
- IUPAC Condensed
- GlcNAc(b1-
External Links
- GlyConnect structure
- GlyGen
- ChEBI
- PubChem Compound
- PubChem Substance
- The Human Metabolome Database
- CarbBank
-
- 9
- 3780
- 3968
- 4708
- 25653
- 28493
- 29021
- 29527
- 29549
- 31775
- 32028
- 32903
- 33539
- 36048
- 36270
- 37035
- 37525
- 37675
- 37677
- 37678
- 39452
- 39454
- 39456
- 39609
- 39611
- 39613
- 39614
- 40149
- 40150
- 40151
- 40355
- 40591
- 40600
- 42059
- 42207
- 42220
- 43184
- 43893
- 43925
- 43926
- 43931
- 43932
- 43941
- 44395
- 44396
- 44397
- 44549
- 46453
- 47268
- 47468
- 47537
- 47603
- 47796
- 48630
- 48812
- 48813
- 49006
- 49732
- 50589
- 50736
3D Structures
- GLYCAM
- DGlcpNAcb1-OH
G14843DJ
G68544GH
Organisms
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) | |
| Drosophila melanogaster (fruit fly) | |
| Streptococcus pneumoniae |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT2 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT1 | UDP-Gal |
G49108TO
|
R |
G00055MO
|
R | |
| B3GALT5 | UDP-Gal |
G49108TO
|
R |
G00056MO
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-Benzl |
G00055MO
|
[beta]-1-Benzl | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-4-methyl-umbelliferyl |
G00055MO
|
[beta]-1-4-methyl-umbelliferyl |
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9UPU5 | Ubiquitin carboxyl-terminal hydrolase 24 | ||
| Q9UPV9 | Trafficking kinesin-binding protein 1 | ||
| Q9UPW6 | DNA-binding protein SATB2 | ||
| Q9UPX0 | Protein turtle homolog B | ||
| Q9UPX8 | SH3 and multiple ankyrin repeat domains protein 2 | ||
| Q9UPY5 | Cystine/glutamate transporter | ||
| Q9UPZ3 | BLOC-2 complex member HPS5 | ||
| Q9UQ26 | Regulating synaptic membrane exocytosis protein 2 | ||
| Q9UQ35 | Serine/arginine repetitive matrix protein 2 | ||
| Q9UQ52 | Contactin-6 |
GlycoEpitope
- Epitope ID
- EP0004
Pathway
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Xenopus tropicalis |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Danio rerio |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Homo sapiens |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35138101 | Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells | He J | 2022 Feb 09 |
|
| 35140400 | Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias | Hu C | 2022 Feb 09 |
|
| 35140402 | Mechanisms of inhibition and activation of extrasynaptic αβ GABAA receptors | Kasaragod VB | 2022 Feb 09 |
|
| 35132862 | Simultaneously Identifying and Distinguishing Glycoproteins with O-GlcNAc and O-GalNAc (the Tn Antigen) in Human Cancer Cells | Xu S | 2022 Feb 08 |
|
| 34990590 | Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization | Weber T | 2022 Feb 08 |
|
| 35114110 | Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display | Tanaka S | 2022 Feb 08 |
|
| 35136084 | Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer | Yang Z | 2022 Feb 08 |
|
| 35136060 | Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate | Liu S | 2022 Feb 08 |
|
| 35131851 | Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions | Milder FJ | 2022 Feb 07 |
|
| 34999257 | Crystal structure and substrate recognition mechanism of the prolyl endoprotease PEP from Aspergillus niger | Miyazono K | 2022 Feb 05 |
|
